A Look at the Current Status of the CRISPR Patent Interferences Involving Broad Institute, University of California and University of Vienna, ToolGen, and Sigma-Aldrich

Christopher M. Holman (University of Missouri), A Look at the Current Status of the CRISPR Patent Interferences Involving Broad Institute, University of California and University of Vienna, ToolGen, and Sigma-Aldrich, 41 Biotechnology L. Rep. 169 (2022):

This article reports on recent developments in patent interference proceedings relating to use of CRISPR-Cas9 for gene editing in a eukaryotic environment. The article begins with a brief overview of some substantive and procedural aspects of patent interference law of particular relevance to these proceedings, followed by a summary of the status of the interferences at the time this article was written, based primarily on information gleaned from the declarations of interference and motions filed by the various parties. It concludes with some thoughts on how things might ultimately settle out in the fight to control the patents in this important technological space.